Dr. Yang Wang, MD

Dr. Wang practices at Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico.

Dr. Wang's NPI, 1073810966, was assigned on February 11, 2011. Dr. Wang holds New Mexico license MD2015-0604.

Dr. Wang's primary practice is Rust Pmg Cardiology - HOPD, at 2400 Unser Blvd SE, Rio Rancho, NM 87124.

Dr. Wang's primary practice is Rust Pmg Cardiology - HOPD in Rio Rancho, New Mexico. Dr. Wang is also affiliated with Presbyterian Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Wang to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is board certified in hematology by the American Board of Internal Medicine. Dr. Wang is licensed in New Mexico.

CMS data shows 721 Medicare services from Dr. Wang across 7 procedure codes in 2024, for 322 Medicare patients. Medicare paid $56,536 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 322 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 134 patients. 66% of them have high cholesterol, and 62% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 72, with 56% women.

In 2024, Dr. Wang wrote 2,206 Medicare Part D claims for 391 patients. 76% of them were for generic drugs. CMS names the drug for 1,895 of them, across 45 drugs with 11 or more claims each, at $4,912,483 in total drug cost. In 2023, CMS named 1,508 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 78 papers to Dr. Wang, published from 2011 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Cell Line, Tumor, Arabidopsis and Cell Wall. Dr. Wang has published most often in J Phys Chem A. Dr. Wang's most frequent co-authors are Abigail Suzanne Caudle, MD, Matthew J. Ellis, MD, PhD and Adit A. Ginde, MD.

CMS Open Payments shows 247 general payments to Dr. Wang from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $469.